Tower Research Capital LLC (Trc) Ionis Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,045 shares of IONS stock, worth $217,869. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,045
Previous 1,581
92.6%
Holding current value
$217,869
Previous $62,000
220.97%
% of portfolio
0.01%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding IONS
# of Institutions
507Shares Held
155MCall Options Held
2.69MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.18 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.2MShares$941 Million0.53% of portfolio
-
Capital World Investors Los Angeles, CA12.7MShares$910 Million0.12% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$738 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.59MShares$471 Million0.08% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.2B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...